Silo Pharma, Inc. announced that on September 27, 2022, the Company's Board of Directors appointed Jeff Pavell as a member of the Board. Dr. Pavell was appointed to fill the vacancy created by an increase in the size of the Board of Directors to four (4) directors. Dr. Pavell will serve as a director until his successor is duly elected and qualified.

On September 27, 2022, the Board appointed Mr. Pavell as a member of the audit committee, member of the compensation committee, and chair of the nominating and corporate governance committee. Dr. Pavell, age 55, has over 20 years of medical experience. Since January 2021, Dr. Pavell has served as a director of FoxWayne Enterprises Acquisition Corp.

Since October 1999, Dr. Pavell has served as an Attending Physician at the Physical Medicine and Rehabilitation Center, P.A., a diagnostic and treatment facility that specializes in treating sports, spine, orthopedic and neuromuscular conditions. Since January 2000, Dr. Pavell has served as the Chief of Rehabilitation Medicine at Englewood Hospital and Medical Center. Since April 2002, Dr. Pavell has served as the Associate Director of Pain Medicine at the Center for Advanced Surgery in Paramus, New Jersey.

Since April 2002, Dr. Pavell has been an Instructor in Clinical Rehabilitation at Columbia University's College of Physicians & Surgeons. Dr. Pavell holds a Doctor of Medicine degree from the New York College of Osteopathic Medicine and a Bachelor of Art degree in Political Science from John Hopkins University. Company believe that Dr. Pavell is qualified to serve as a member of board of directors due to his medical background and experience practicing in the healthcare industry.